SCHEMBL3544819

SCHEMBL3544819

CCCc1cc(C(=O)OC)cc(OC)c1OS(=O)(=O)C(F)(F)F

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PPARG P37231 5/20 0.46
PPARA Q07869 5/20 0.46
TSHR P16473 2/20 0.40
KDM4E B2RXH2 4/20 0.37
NOTUM Q6P988 2/20 0.36
THRB P10828 1/20 0.36
CYP3A4 P08684 2/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
TPMT P51580 1/20 0.36
MAPT P10636 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
USP2 O75604 1/20 0.36
ALDH1A1 P00352 3/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
ALOX5 P09917 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24857231 0.86 TPMT (0.44) TSHRKDM4ENOTUMTHRBCYP3A4
SCHEMBL3546673 0.82 PPARG (0.53) PPARGPPARATSHRKDM4ECYP3A4
SCHEMBL17893866 0.81 TUBB1 (0.44) TSHRKDM4ENOTUMTHRBCYP3A4
SCHEMBL25977472 0.81 THRB (0.46) TSHRKDM4ENOTUMTHRBCYP3A4
SCHEMBL36007 0.81 PPARG (0.43) PPARGPPARATSHRKDM4ENOTUM
SCHEMBL2470307 0.80 ALDH1A1 (0.48) KDM4ETHRBCYP3A4CYP2C9CYP2C19
SCHEMBL22026532 0.80 TSHR (0.47) TSHRKDM4ENOTUMTHRBTPMT
SCHEMBL22491439 0.76 VCAM1 (0.46) TSHRKDM4ECYP3A4TPMTMAPT
SCHEMBL2668281 0.75 CYP4F2 (0.40) PPARGPPARAKDM4ENOTUMALDH1A1
SCHEMBL730998 0.75 NOTUM (0.44) KDM4ENOTUMTHRBCYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7691843-B2 N-hydroxyamide derivatives possessing antibacterial activity PFIZER INC. (US) 2010-04-06 US disclosed
US-20080058304-A1 N-hydroxyamide derivatives possessing antibacterial activity VICURON HOLDINGS LLC 2008-03-06 US disclosed
EP-1539744-A4 N-HYDROXYAMIDE DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY VICURON PHARM INC (US) 2007-06-06 EP disclosed
EP-1539744-A2 N-HYDROXYAMIDE DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY Vicuron Pharmaceuticals, Inc. (US) 2005-06-15 EP disclosed
WO-2004007444-A2 N-HYDROXYAMIDE DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY VICURON PHARMACEUTICALS, INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080058304-A1 N-hydroxyamide derivatives possessing antibacterial activity AMDHD2, OGA, ENGASE PPARG 4024/4885PPARA 3704/4885TSHR 3540/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.